iBio, Inc. (IBIO): Operating Cash Flow
-$23.22M
Year ended 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$23.22M | n/m | 2026-08-28, From 2025-07-01 |
| 2025-06-30 | -$15.30M | n/m | 2026-08-28, From 2024-07-01 |
| 2024-06-30 | -$18.55M | n/m | 2025-09-05, From 2023-07-01 |
| 2023-06-30 | -$30.44M | n/m | 2024-09-24, From 2022-07-01 |
| 2022-06-30 | -$37.48M | n/m | 2023-09-27, From 2021-07-01 |
| 2021-06-30 | -$30.06M | n/m | 2022-10-11, From 2020-07-01 |
| 2020-06-30 | -$13.35M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | -$13.97M | n/m | 2020-10-13, From 2018-07-01 |
| 2018-06-30 | -$13.48M | n/m | 2019-08-26, From 2017-07-01 |
| 2017-06-30 | -$13.16M | n/m | 2018-09-18, From 2016-07-01 |
| 2016-06-30 | -$8.07M | n/m | 2017-09-15, From 2015-07-01 |
| 2015-06-30 | -$4.72M | n/m | 2016-10-13, From 2014-07-01 |
| 2014-06-30 | -$4.12M | n/m | 2015-10-13, From 2013-07-01 |
| 2013-06-30 | -$4.85M | n/m | 2013-10-04, From 2012-07-01 |
| 2012-06-30 | -$6.01M | n/m | 2013-10-04, From 2011-07-01 |
| 2011-06-30 | -$5.34M | n/a | 2012-10-15, From 2010-07-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| iBio, Inc. (IBIO) | 2026-06-30 | -$23.22M | n/m |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | -$24.58M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$5.52M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$17.95M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.66M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$88.63M | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$51.21M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$51.46M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$15.95M | n/m |
Compare IBIO, ATNM, BFRG, SER side by side · Screen every company in Pharmaceutical Preparations ↗